Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KYLE LAMAR GUMMELT

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1689964215
CMS profile
553599
Location
DALLAS, TX

General Payments · PY2018–2024

$1,698.08

  • Reported across 77 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$368.13

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $368.13 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $134.17 2
NOVARTIS PHARMACEUTICALS CORPORATION $54.45 2
Cleerly, Inc. $46.42 1
GlaxoSmithKline, LLC. $36.26 2
Abbott Laboratories $35.42 2
Lilly USA, LLC $28.65 2
Amgen Inc. $17.95 1
SANOFI-AVENTIS U.S. LLC $14.81 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $506.11 30
PY2019 $234.87 13
PY2020 $27.56 2
PY2021 $106.60 6
PY2022 $260.40 4
PY2023 $194.41 9
PY2024 $368.13 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $13.93 04/02/2024 Food and Beverage Undisputed 01/23/2026 1125200420 CMS
Abbott Laboratories $21.49 10/11/2024 Food and Beverage Undisputed 01/23/2026 1125200422 CMS
Amgen Inc. $17.95 06/05/2024 Food and Beverage Undisputed 01/23/2026 1117267979 CMS
Cleerly, Inc. $46.42 02/28/2024 Food and Beverage Undisputed 01/23/2026 1144710714 CMS
GlaxoSmithKline, LLC. $19.08 10/09/2024 Food and Beverage Undisputed 01/23/2026 1116529624 CMS
GlaxoSmithKline, LLC. $17.18 12/16/2024 Food and Beverage Undisputed 01/23/2026 1115774943 CMS
Lilly USA, LLC $15.12 02/26/2024 Food and Beverage Undisputed 01/23/2026 1135138826 CMS
Lilly USA, LLC $13.53 05/14/2024 Food and Beverage Undisputed 01/23/2026 1135143241 CMS
Novartis Pharmaceuticals Corporation $26.29 07/30/2024 Food and Beverage Undisputed 01/23/2026 1086948695 CMS
Novartis Pharmaceuticals Corporation $28.16 10/07/2024 Food and Beverage Undisputed 01/23/2026 1086948725 CMS
Novo Nordisk Inc $16.41 03/26/2024 Food and Beverage Undisputed 01/23/2026 1097514932 CMS
Novo Nordisk Inc $117.76 10/17/2024 Food and Beverage Undisputed 01/23/2026 1096933449 CMS
SANOFI-AVENTIS U.S. LLC $14.81 10/29/2024 Food and Beverage Undisputed 01/23/2026 1139781311 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.